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The need for preventing influenza and its
complications through vaccination in patients
aged over 65 years has been clearly demonstrated
[1–5]. Numerous studies showed however that
vaccination coverage of the target population re-
mains low, whatever the strategies of implementa-
tion [6–11]. We achieved a considerable improve-
ment of our coverage rate through the interven-
tion of a medical personnel proposing the vaccine
prior to the medical consultation; the rate of re-
fusals fell down to 9% in the over 65 age group.
The strategy and results are detailed in another
paper [12]. 
In most studies reporting coverage rate, the
non-vaccinated patients were implicitly consid-
ered as having refused the injection, although the
reason was often different (injection performed
elsewhere or later, temporary contraindication,
negligence of the patient or the doctor, no medical
contact, etc.) [13]. Reviews of studies have men-
tioned prevalence rates for the refusal of influenza
vaccination varying between 9 and 66% [6, 10, 12,
14–16]; some authors reported the motives of re-
fusal [8, 14, 15, 17] but none of them described
these motives in detail. This is however a crucial
information in order to improve the coverage rate
in the elderly [18] and is the main focus of the pres-
ent report. According to the literature, the most
frequent reasons for refusal reported by the pa-
tients are: fear or previous experience of adverse
events related to the vaccine, absence of efficacy of
the vaccine, fear of injections, underestimation of
influenza complications, a perceived good health,
and not having had influenza or not having had the
vaccine in the past [8, 14, 15, 17].
Until now, few studies analysed the potential
risk factors for refusal, in particular the demo-
graphical and behavioural characteristics in elderly
patients [14]. Such an investigation would allow to
identify groups at risk for refusing the vaccination,
and develop an information strategy targeted on
these persons [19, 20].
With the aim of investigating the true motives
as well as the potential risk factors for refusal, we
recorded the attitude towards the vaccine in el-
derly patients attending the Medical Outpatient
Clinic, University of Lausanne (MOC) and private
practices (Orbe and Neuchâtel) during the vacci-
More knowledge on the reasons for refusal of
the influenza vaccine in elderly patients is essential
to target groups for additional information, and
hence improve coverage rate. The objective of the
present study was to describe precisely the true
motives for refusal. All patients aged over 64 who
attended the Medical Outpatient Clinic, Univer-
sity of Lausanne, or their private practitioner’s of-
fice during the 1999 and 2000 vaccination periods
were included. Each patient was informed on in-
fluenza and its complications, as well as on the need
for vaccination, its efficacy and adverse events. The
vaccination was then proposed. In case of refusal,
the reasons were investigated with an open ques-
tion. Out of 1398 patients, 148 (12%) refused the
vaccination. The main reasons for refusal were the
perception of being in good health (16%), of not
being susceptible to influenza (15%), of not hav-
ing had the influenza vaccine in the past (15%), of
having had a bad experience either personally or a
relative (15%), and the uselessness of the vaccine
(10%). Seventeen percent gave miscellaneous rea-
sons and 12% no reason at all for refusal. Little
epidemiological knowledge and resistance to
change appear to be the major obstacles for wide
acceptance of the vaccine by the elderly.
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nation period of the winter of 1999–2000. The
same data collection was performed during the
winter of 2000–2001, but only in the MOC. 
Methods
The Medical Outpatient Clinic, University of Lau-
sanne, is a primary care centre open to the general popu-
lation. There is a selection bias of patients towards
refugees, asylum seekers, foreigners and the elderly with
low income. Patients are seen on appointment or by the
staff on duty if attending spontaneously. As far as the in-
fluenza vaccine is concerned, a walk-in clinic is also es-
tablished for the vaccination period.
During the influenza vaccination period (mid-Octo-
ber to mid-December), each patient over 64 years old was
seen prior to the medical consultation by a medical stu-
dent who informed him/her about influenza and its com-
plications, about the efficacy of the prevention by the vac-
cine and about its potential adverse events. The student
asked about vaccination the previous year, allergy to eggs,
anticoagulant treatment and any febrile illness in the last
few days. At this stage, the patient could choose 1) to be
vaccinated immediately, 2) to discuss further with the doc-
tor or 3) to refuse the vaccination. In the latter case, the
reason was investigated by an open question and discussed
further. 
In the private practitioner’s office, the strategy was
similar, except that the medical secretary instead of the
medical student proposed the vaccination.
The data collection was performed in 1999–2000 and
2000–2001 with the objective to cover all patients over 64.
For prevalence rates calculation, we excluded 198 persons
who came spontaneously for vaccination to the walk-in
clinic but were not followed regularly at the MOC. These
patients were nonetheless included in the risk factors
analysis. 
We analysed the data to determine the prevalence rate
of refusals as well as the reasons given by the patients. We
classified them into 5 main groups: 1) reasons related to
the patient, 2) reasons related to the vaccine, 3) practical
reasons, 4) other reasons, 5) no reason. Within these
groups, we made 22 subclasses to report precisely the re-
sponses of the patients. The risk factors for refusal were
analysed using multivariate logistic regression (Stata ver-
sion 7). Variables included in the model were sex, origin,
regular follow-up and vaccination in the previous year.
Results
A total of 1398 questionnaires were filled by
all the patients aged over 64 who attended the
MOC and the 5 medical practices during the
vaccination period of 1999–2000, and those who
attended the MOC only in 2000–2001. Of these,
198 persons who came spontaneously to the walk-
in clinic were not followed regularly by a physician
at the MOC. The demographical characteristics
and prevalence rates of refusals per year and health
facility are detailed in Table 1. 
During the 1999–2000 season, 404 patients
were included at the MOC and 12% refused to be
vaccinated. Another 598 patients were included in
the private practitioners’ offices of which 14% re-
fused the vaccination. Among the 124 patients who
refused the vaccine, 120 (97%) did not receive the
vaccine the year before and 36 (29%) had a regu-
lar medical follow up. 
In 2000–2001, 396 patients were included at
the MOC and 9% refused to be vaccinated. Among
the 24 patients who refused, 9 (38%) did not get
vaccinated the year before and 19 (79%) had a reg-
ular medical follow up.
The detailed reasons for refusal are described
in Table 2. The main reasons were related to the
person, i.e. perception of good health, impression
to be at low risk for the disease, and not having had
the vaccine in the past. Among other motives re-
lated to the vaccine, the main one for refusing was
a bad previous experience, either of the patient or
of a parent and the opinion that the vaccine was
not necessary. 
Seven MOC patients were included during the
two seasons and refused the vaccination twice. All
but one gave different reasons on each occasion. 
Table 3 shows the risk factors for refusing vac-
cination: after adjustment, the Swiss origin and
never having had the shot were significant risk fac-
tors for refusal.
Year health facility total nb mean age male female nb of refusals % of refusals
of patients (range) (%) (%)
1999–2000 MOC walk-in 77 73 (65–88) 57 43 NA NA
MOC regular 327 74 (65–97) 55 45 40 12
private practices 598 74 (65–99) 38 62 84 14
2000–2001 MOC walk-in 118 73 (65–90) 47 53 NA NA
MOC regular 278 75 (65–98) 57 43 24 9
Total 1398 74 47 53 148/1203 12
NA = not applicable
Table 1
Demographical char-
acteristics and preva-
lence rates of refusal
according to season
and health facility.
Reasons for refusal 1999–2000 2000–2001
MOC private practices MOC total
n (%) n (%) n (%) n (%)
Related to the person 31 (78) 50 (60) 14 (58) 95 (64)
Good health 7 (18) 14 (17) 2 (8) 23 (16)
Too young for the vaccine to be necessary 2 (5) 0 (0) 0 (0) 2 (1)
Not at risk for influenza 7 (18) 10 (12) 5 (21) 22 (15)
Sufficient immunity, want to fight by myself 4 (10) 3 (4) 0 (0) 7 (5)
Other more important health problems 1 (3) 0 (0) 0 (0) 1 (1)
Too old to be vaccinated 2 (5) 0 (0) 0 (0) 2 (1)
Wants to die and refuse any prevention 1 (3) 0 (0) 0 (0) 1 (1)
Must die one day or another from influenza or other disease 1 (3) 0 (0) 2 (8) 3 (2)
Opposed to vaccines and drugs 5 (13) 1 (1) 2 (8) 8 (5)
Has never been vaccinated against influenza 0 (0) 21 (25) 1 (4) 22 (15)
Does not want to change his/her habits 1 (3) 1 (1) 2 (8) 4 (3)
Related to the vaccine 20 (50) 22 (26) 12 (50) 54 (37)
Fear of adverse events 4 (10) 1 (1) 3 (13) 8 (5)
Bad experience himself or of a relative 5 (13) 14 (17) 3 (13) 22 (15)
Fear of injections 2 (5) 1 (1) 1 (4) 4 (3)
Vaccine is useless, not necessary 6 (15) 4 (5) 4 (17) 14 (10)
Vaccine is not efficacious 2 (5) 2 (2) 1 (4) 5 (3)
Medicine is incompetent 1 (3) 0 (0) 0 (0) 1 (01)
Logistical reasons 1 (3) 1(1) 3 (13) 5 (3)
Prefers alternative medicine (homeopathy) 0 (0) 1 (1) 0 (0) 1 (1)
Wants to be vaccinated later 1 (3) 0 (0) 3 (13) 4 (3)
Other reasons 5 (13) 1 (1) 2 (8) 8 (5)
Lack or bad information 1 (3) 1 (1) 0 (0) 2 (1)
Refusal decided by another person 2 (5) 0 (0) 0(0) 2 (1)
Fear of interference with diet; thinks that it is a way to 2 (5) 0 (0) 2 (8) 4 (3)
earn money; fears that the vaccine will not be reimbursed
No reason 4 (10) 12 (14) 1 (4) 18 (12)
No response 2 (5) 1 (1) 2 (8) 5 (3)
Total* 63 (158) 87 (104) 34 (142) 185 (125)
* The total exceeds 100% since most patients gave several reasons for refusing vaccination (0–4 responses). 
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This study demonstrated that the prevalence
rate of vaccination refusal is much lower when the
vaccination is proposed in the best possible condi-
tions (person dedicated for this task, time available
for information and questions, etc.) than when no
incentive strategy is in place [12]. This indicates
that the majority of non-vaccinations in the elderly
population is not due to refusal, but to the logisti-
Table 2
Refusal numbers and
categories according
to season and health
facility.
Characteristics prevalence rate crude p value adjusted p value
or means Odd Ratio Odd Ratio 
Refusal Vaccinated (95% Cl) (95% Cl)
Age (years) 74 74 0,45
Sex female 57 52 1,25 (0,87–1,79) 0,24
Origin Switzerland 
(only in 487 MOC patients) 89 82 1,89 (0,86–4,63) 0,17 2,4 (1,03–5,6) 0,02
Regular follow up 37 40 0,88 (0,6–1,27) 0,51
No vaccination in the preceding year (%) 91 19 42 (23–77) <0,001 15,9 (7,6–33,1) <0,001
Table 3
Risk factors 
for refusal.
Discussion
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cal or maybe financial difficulties to establish a
strategy that allows to reach, inform and poten-
tially convince the target population. If the indi-
vidual can give his/her opinion or ask questions
without being stigmatised, he/she may be more re-
ceptive to the arguments given by the medical per-
sonnel and may accept the vaccination easily. It
also seems that the time spent by the person in
charge of vaccination to give accurate information
is pre-eminent in order for the recipient to accept.
Our study showed that the main reasons for re-
fusal are linked to the perception of the patient of
his/her good health and to self-estimation of
his/her risk of disease. The patients often men-
tioned that he/she wants his/her body to fight the
disease without external help. The evaluation of
the individual risk is totally subjective. To question
this perception, the patient would need to have
some kind of epidemiological background as well
as an understanding of the difference between the
individual and the population level of risk.
The second group of refusals included the rea-
sons related to the vaccine or to the supposed effi-
cacy of medicine. It is interesting to note that the
beliefs and fears about potentially severe adverse
events of the vaccine lead to a significant propor-
tion of refusals. On the other hand, there seems to
be little concern about influenza morbidity or
complications, even after clear and objective ex-
planations. Similarly, the experience of a relative
(whether positive or negative) weighs more in the
decision-making than any medical or official talk
on the question [19]. Also, reports by the media of
a reduced efficacy of the vaccine in the years when
the vaccine strains did not match the circulating
ones may have had an important impact on public
opinion. Now, numerous individuals may be con-
vinced that the vaccine is useless. The short-term
protection, the necessity of repeated immunisa-
tions and the limited period to be vaccinated are
probably all reasons for a diminished acceptance
and coverage of immunisation.
Intuitive knowledge coupled with the results
of some previous studies [21] would place fear of
injection as one of the main reasons for refusal but
unexpectedly, only 3% of the patients stated that it
is why they refused. One can argue that the pa-
tients did not dare to mention this reason and gave
a more reasonable one. The fact that so few pa-
tients fear the injection goes against the efforts of
some experts promoting the use of vaccine admin-
istered through the mucosal route to improve
compliance. Actually, it would be more important
to insist on the reduction of virus transmission and
on the potential improvement of protection con-
ferred by the intranasal vaccine against heterolo-
gous strains rather than on the easy and painless
administration of the vaccine.
Resistance to changing one’s habits is a major
reason for refusal: 15% of those who did not want
to be vaccinated argued that they had never been
vaccinated in the past and therefore did not see
why they should. One way of decreasing the num-
ber of refusals would be to reach this population at
a younger age, when it may be easier to adapt to
new behaviours.
Our results show that foreign people living in
Switzerland better accept the immunisation than
the Swiss population, perhaps because they have
more respect for physicians in their culture or be-
cause they don’t speak French good enough to
protest … The fact that never having had the shot
is a risk factor for refusing it again denotes the dif-
ficulty of changing one’s habits.
Some may argue that the study is limited by
the strategy of information and interview chosen
that were rather directive. We think that the use of
an open question allowed some freedom to the pa-
tients. The fact that it was not the usual doctor who
proposed the vaccination may also have left the pa-
tient with more freedom to choose refusal. The
type of population, namely the patients recruited
at the MOC who were from various cultural back-
grounds, may have biased the results when com-
pared to a typical Swiss population. The fact that
the results were almost similar in the private prac-
tices validates the findings at the MOC. Also, since
different populations were included, the conclu-
sion is probably reasonably representative of all
kinds of elderly populations. 
Conclusion
The reasons for refusal of the influenza vac-
cine in Switzerland are mainly related to subjective
beliefs of the patient on his/her health status and
susceptibility to influenza as well as to his/her
opinion on vaccine efficacy. Resistance to chang-
ing one’s behaviour seems to be a major obstacle
to the universal vaccination of elderly patients. An
information targeted on a slightly younger popu-
lation (i.e. at the age of 60 or 65) may be more ef-
fective in order to improve vaccination coverage
against influenza.
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